Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Pharm |
RCV000211134 | SCV000268199 | drug response | hmg coa reductase inhibitors response - Toxicity/ADR | 2016-07-11 | reviewed by expert panel | curation | PharmGKB Level of Evidence 2B: Annotation for a variant-drug combination with moderate evidence of an association. The association must be replicated but there may be some studies that do not show statistical significance, and/or the effect size may be small. |
Pharm |
RCV000211259 | SCV000268200 | drug response | simvastatin response - Toxicity/ADR | 2016-07-11 | reviewed by expert panel | curation | PharmGKB Level of Evidence 2B: Annotation for a variant-drug combination with moderate evidence of an association. The association must be replicated but there may be some studies that do not show statistical significance, and/or the effect size may be small. |